Effects of modifiers of glycosaminoglycan biosynthesis on outflow facility in perfusion culture

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 6, 2008, Pages 2495-2505

  Keller, Kate E ^a   Bradley, John M ^a   Kelley, Mary J ^a   Acott, Ted S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA XYLOSIDE; CHLORATE; CHONDROITIN; DISACCHARIDE; FIBRONECTIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; PARAFFIN; SODIUM CHLORATE; TENASCIN; UNCLASSIFIED DRUG; XYLOSE; CHONDROITIN SULFATE; GLYCOSIDE; HYALURONIC ACID; XYLOSIDES;

ADDITION REACTION; ANIMAL CELL; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LACRIMAL DUCT; NONHUMAN; ORGAN CULTURE; PERFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SULFATION; SWINE; TRABECULAR MESHWORK; AGED; ANIMAL; AQUEOUS HUMOR; DRUG EFFECT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METABOLISM; MIDDLE AGED; ORGAN CULTURE TECHNIQUE; SECRETION;

AGED; AGED, 80 AND OVER; ANIMALS; AQUEOUS HUMOR; CELLS, CULTURED; CHLORATES; CHONDROITIN SULFATES; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOSAMINOGLYCANS; GLYCOSIDES; HEPARITIN SULFATE; HUMANS; HYALURONIC ACID; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; SWINE; TENASCIN; TRABECULAR MESHWORK;

EID: 47249088603     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-0903     Document Type: Article

References (69)

1. Sasisekharan R, Raman R, Prabhakar V. Glycomics approach to structure-function relationships of glycosaminoglycans. Annu Rev Biomed Eng. 2006;8:181-231. (Pubitemid 44314816)
2. Davies JA, Fisher CE, Barnett MW. Glycosaminoglycans in the study of mammalian organ development. Biochem Soc Trans. 2001;29:166-171. (Pubitemid 32587498)
3. Silbert JE, Sugumaran G. Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life. 2002;54:177-186. (Pubitemid 36008326)
4. Sugahara K, Kitagawa H. Heparin and heparan sulfate biosynthesis. IUBMB Life. 2002;54:163-175. (Pubitemid 36008325)
5. Prydz K, Dalen KT. Synthesis and sorting of proteoglycans. J Cell Sci. 2000;113:193-205.
6. Scott JE. Extracellular matrix, supramolecular organisation and shape. J Anat. 1995;187:259-269.
7. Knepper PA, Goossens W, Hvizd M, Palmberg PF. Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1360-1367. (Pubitemid 26177312)
8. Tawara A, Varner HH, Hollyfield JG. Distribution and characterization of sulfated proteoglycans in the human trabecular tissue. Invest Ophthalmol Vis Sci. 1989;30:2215-2231. (Pubitemid 19259928)
9. Gong H, Freddo TF, Johnson M. Age-related changes of sulfated proteoglycans in the normal human trabecular meshwork. Exp Eye Res. 1992;55:691-709.
10. Johnson M. What controls aqueous humour outflow resistance? Exp Eye Res. 2006;82:545-557. (Pubitemid 43122085)
11. Francois J. The importance of the mucopolysaccharides in intraocular pressure regulation. Invest Ophthalmol. 1975;14:173-176.
12. Knepper PA, Goossens W, Palmberg PF. Glycosaminoglycan stratification of the juxtacanalicular tissue in normal and primary openangle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:2414-2425. (Pubitemid 26391279)
13. Barany EH, Scotchbrook S. Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand. 1954;30:240-248.
14. Peterson WS, Jocson VL. Hyaluronidase effects on aqueous outflow resistance: quantitative and localizing studies in the rhesus monkey eye. Am J Ophthalmol. 1974;77:573-577.
15. Van Buskirk EM, Brett J. The canine eye: in vitro studies of the intraocular pressure and facility of aqueous outflow. Invest Ophthalmol Vis Sci. 1978;17:373-377. (Pubitemid 8301758)
16. Gum GG, Samuelson DA, Gelatt KN. Effect of hyaluronidase on aqueous outflow resistance in normotensive and glaucomatous eyes of dogs. Am J Vet Res. 1992;53:767-770.
17. Knepper PA, Farbman AI, Telser AG. Exogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye. Invest Ophthalmol Vis Sci. 1984;25:286-293. (Pubitemid 14164776)
18. Sawaguchi S, Lam TT, Yue BY, Tso MOM. Effects of Glycosaminoglycan- degrading enzymes on bovine trabecular meshwork in organ culture. J Glaucoma. 1993;2:80-86. (Pubitemid 23194476)
19. Sawaguchi S, Yue BY, Yeh P, Tso MO. Effects of intracameral injection of chondroitinase ABC in vivo. Arch Ophthalmol. 1992;110:110-117.
20. Hubbard WC, Johnson M, Gong H, et al. Intraocular pressure and outflow facility are unchanged following acute and chronic intracameral chondroitinase ABC and hyaluronidase in monkeys. Exp Eye Res. 1997;65:177-190. (Pubitemid 27360148)
21. Pedler C. The relationship of hyaluronidase to aqueous outflow resistance. Trans Ophthalmol Soc UK. 1956;76:51-63.
22. Francois J, Rabaey M, Neetens A. Perfusion studies on the outflow of aqueous humor in human eyes. Arch Ophthalmol. 1956;55:193-204.
23. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol. 1963;69:783-801.
24. Greve H, Cully Z, Blumberg P, Kresse H. Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J Biol Chem. 1988;263:12886-12892. (Pubitemid 18238348)
25. Klaassen CD, Boles JW. Sulfation and sulfotransferases 5: the importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J. 1997;11:404-418.
26. Safaiyan F, Kolset SO, Prydz K, Gottfridsson E, Lindahl U, Salmivirta M. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem. 1999;274:36267-36273. (Pubitemid 30005226)
27. Gorsi B, Stringer SE. Tinkering with heparan sulfate sulfation to steer development. Trends Cell Biol. 2007;17:173-177. (Pubitemid 46507809)
28. Kusche-Gullberg M, Kjellen L. Sulfotransferases in glycosaminoglycan biosynthesis. Curr Opin Struct Biol. 2003;13:605-611. (Pubitemid 37244116)
29. Schwartz NB, Galligani L, Ho PL, Dorfman A. Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells. Proc Natl Acad Sci USA. 1974;71:4047-4051.
30. Hahn RA, Birk DE. beta-D xyloside alters dermatan sulfate proteoglycan synthesis and the organization of the developing avian corneal stroma. Development. 1992;115:383-393.
31. Bachmann B, Birke M, Kook D, Eichhorn M, Lütjen-Drecoll E. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol Vis Sci. 2006;47:2011-2020. (Pubitemid 46768283)
32. Vittal V, Rose A, Gregory KE, Kelley MJ, Acott TS. Changes in gene expression by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2005;46:2857-2868. (Pubitemid 43086708)
33. Keller KE, Kelley MJ, Acott TS. Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci. 2007;48:1164-1172.
34. Bradley JM, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658. (Pubitemid 28558223)
35. Bradley JM, Anderssohn AM, Colvis CM, et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1β and TNFα. Invest Ophthalmol Vis Sci. 2000;41:422-430. (Pubitemid 30080445)
36. Kelley MJ, Rose AY, Song K, et al. Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork. Invest Ophthalmol Vis Sci. 2007;48:2634-2643.
37. Morris NP, Oxford JT, Davies GB, Smoody BF, Keene DR. Developmentally regulated alternative splicing of the alpha1(XI) collagen chain: spatial and temporal segregation of isoforms in the cartilage of fetal rat long bones. J Histochem Cytochem. 2000;48:725-741. (Pubitemid 30366607)
38. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
39. Polansky JR, Weinreb RN, Baxter JD, Alvarado J. Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci. 1979;18:1043-1049. (Pubitemid 9253760)
40. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
41. Grierson I, Howes RC. Age-related depletion of the cell population in the human trabecular meshwork. Eye. 1987;1:204-210. (Pubitemid 17133335)
42. Alvarado J, Murphy C, Polansky J, Juster R. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci. 1981;21:714-727. (Pubitemid 12229217)
43. May CA, Skorski LM, Lütjen-Drecoll E. Innervation of the porcine ciliary muscle and outflow region. J Anat. 2005;206:231-236. (Pubitemid 40424841)
44. McMenamin PG, Steptoe RJ. Normal anatomy of the aqueous humour outflow system in the domestic pig eye. J Anat. 1991;178:65-77.
45. Kluppel M, Wight TN, Chan C, Hinek A, Wrana JL. Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development. 2005;132:3989-4003. (Pubitemid 41410261)
46. Diskin S, Kumar J, Cao Z, et al. Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2006;47:1491-1499. (Pubitemid 46780757)
47. Baeuerle PA, Huttner WB. Chlorate: a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun. 1986;141:870-877. (Pubitemid 17001937)
48. Acott TS, Kingsley PD, Samples JR, Van Buskirk EM. Human trabecular meshwork organ culture: morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci. 1988;29:90-100. (Pubitemid 18038775)
49. Kresse H, Seidler DG, Muller M, et al. Different usage of the glycosaminoglycan attachment sites of biglycan. J Biol Chem. 2001;276:13411-13416. (Pubitemid 37385275)
50. Yanagishita M, Hascall VC. Cell surface heparan sulfate proteoglycans. J Biol Chem. 1992;267:9451-9454.
51. Heinegard D, Paulsson M. Structure and metabolism of proteoglycans. In: Piez KA, Reddi AH, eds. Extracellular Matrix Biochemistry. New York: Elsevier Science; 1984:277-328.
52. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol. 2002;14:617-623. (Pubitemid 35247746)
53. Santas AJ, Peterson JA, Halbleib JL, Craig SE, Humphries MJ, Peters DM. Alternative splicing of the IIICS domain in fibronectin governs the role of the heparin II domain in fibrillogenesis and cell spreading. J Biol Chem. 2002;277:13650-13658. (Pubitemid 34967965)
54. Filla MS, David G, Weinreb RN, Kaufman PL, Peters DM. Distribution of syndecans 1-4 within the anterior segment of the human eye: expression of a variant syndecan-3 and matrix-associated syndecan-2. Exp Eye Res. 2004;79:61-74. (Pubitemid 38737383)
55. Santas AJ, Bahler C, Peterson JA, et al. Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci. 2003;44:4796-4804. (Pubitemid 37315293)
56. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature. 2007;446:1030-1037. (Pubitemid 46676065)
57. Deepa SS, Yamada S, Zako M, Goldberger O, Sugahara K. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. J Biol Chem. 2004;279:37368-37376.
58. Buller C, Johnson D. Segmental variability of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 1994;35:3841-3851. (Pubitemid 24334541)
59. Ethier CR, Chan DW. Cationic ferritin changes outflow facility in human eyes whereas anionic ferritin does not. Invest Ophthalmol Vis Sci. 2001;42:1795-1802. (Pubitemid 32652355)
60. Hann CR, Bahler CK, Johnson DH. Cationic ferritin and segmental flow through the trabecular meshwork. Invest Ophthalmol Vis Sci. 2005;46:1-7. (Pubitemid 40041170)
61. Acott TS, Westcott M, Passo MS, Van Buskirk EM. Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eye. Invest Ophthalmol Vis Sci. 1985;26:1320-1329. (Pubitemid 15241054)
62. Funderburgh JL. Keratan sulfate biosynthesis. IUBMB Life. 2002;54:187-194. (Pubitemid 36008327)
63. Mao Y, Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005;24:389-399. (Pubitemid 41765018)
64. Dallas SL, Chen Q, Sivakumar P. Dynamics of assembly and reorganization of extracellular matrix proteins. Curr Top Dev Biol. 2006;75:1-24.
65. Chung CY, Zardi L, Erickson HP. Binding of tenascin-C to soluble fibronectin and matrix fibrils. J Biol Chem. 1995;270:29012-29017.
66. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M. Tenascin interferes with fibronectin action. Cell. 1988;53:383-390.
67. Chung CY, Erickson HP. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C. J Cell Sci. 1997;110:1413-1419. (Pubitemid 27299937)
68. Midwood KS, Valenick LV, Hsia HC, Schwarzbauer JE. Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol Biol Cell. 2004;15:5670-5677. (Pubitemid 39564757)
69. Huang W, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo A, Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 2001;61:8586-8594. (Pubitemid 33131143)